Difficulty: Medium
Average Score: 69%
Practice
Which one of the following statements about phenytoin is accurate?
Correct answer
D
Rationale
In this question, the correct answer is D) Toxicity occurs with small dose increases. Phenytoin has a narrow therapeutic index, meaning that small changes in dosage can lead to significant changes in blood levels. Even a small increase in dose can result in toxicity symptoms due to nonlinear pharmacokinetics of phenytoin. This is a crucial point to understand when prescribing or administering phenytoin to patients.
Now let's analyze why the other options are incorrect:
A) Phenytoin does not displace sulfonamides from plasma proteins. This statement is false and does not reflect the pharmacological interactions of phenytoin.
B) Phenytoin is not the drug of choice for myoclonic seizures. It is more commonly used for focal seizures, tonic-clonic seizures, and status epilepticus.
C) The half-life of phenytoin decreases with phenobarbital, not increases. Phenobarbital induces the metabolism of phenytoin, leading to a decrease in phenytoin levels.
Educational Context:
Understanding the pharmacology of CNS stimulants like phenytoin is crucial for healthcare professionals, especially those involved in managing patients with seizure disorders. Knowing the nuances of phenytoin's pharmacokinetics can guide appropriate dosing, monitoring for toxicity, and optimizing therapeutic outcomes. This question highlights the importance of being aware of the narrow therapeutic window of phenytoin and the risks associated with small dose adjustments.
Now let's analyze why the other options are incorrect:
A) Phenytoin does not displace sulfonamides from plasma proteins. This statement is false and does not reflect the pharmacological interactions of phenytoin.
B) Phenytoin is not the drug of choice for myoclonic seizures. It is more commonly used for focal seizures, tonic-clonic seizures, and status epilepticus.
C) The half-life of phenytoin decreases with phenobarbital, not increases. Phenobarbital induces the metabolism of phenytoin, leading to a decrease in phenytoin levels.
Educational Context:
Understanding the pharmacology of CNS stimulants like phenytoin is crucial for healthcare professionals, especially those involved in managing patients with seizure disorders. Knowing the nuances of phenytoin's pharmacokinetics can guide appropriate dosing, monitoring for toxicity, and optimizing therapeutic outcomes. This question highlights the importance of being aware of the narrow therapeutic window of phenytoin and the risks associated with small dose adjustments.